Background illustration for clinical trials search

Pulmonary Hypertension Clinical Trials

Browse 652 pulmonary hypertension clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study

for
Type 2 Diabetes, Diabetic Cardiomyopathy, Heart Failure,
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 0+

Code: NCT06593327

Recruiting

Hyperinflation Respiratory Therapies in Cardiac Surgery Patients

for
Pulmonary Disease, Postoperative Complications
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 18 - 70+

Code: NCT04164173

Recruiting

Use of Beta Blockers in Elderly Trauma Patients

for
Multiple Trauma, Cardiovascular Diseases, Aged
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 55+

Code: NCT00302692

Phase 2, Recruiting

Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cells for Pulmonary Diseases

for
Pulmonary Disease, Asthma,
Location: Naples FL
Sponsor: The Foundation for Orthopaedics and Regenerative Medicine

Sex: All

Age: 0+

Code: NCT05147688

Phase 1, Recruiting

Longevity Metrics AI/ML Development Study

for
Aging, Mortality, Cardiovascular Disease Prevention,
Location: Boulder CO
Sponsor: Longevity Metrics, Inc.

Sex: All

Age: 18+

Code: NCT07808619

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Clinical Trial to Evaluate the Effects of an Omega-3-containing Supplement on DHA and EPA Levels in the Blood

for
Omega-3 Deficiency, DHA and EPA Blood Levels,
Location: Las Vegas NV
Sponsor: Revive Active

Sex: All

Age: 18 - 65

Code: NCT07753174

Recruiting

Health Ahead Comparative Effectiveness Study

for
Health Services Accessibility, Rural Health,
Location: Boulder CO
Sponsor: William Brandenburg, MD

Sex: All

Age: 18+

Code: NCT07669168

Recruiting

Prescription of Step Counts for Targeted Changes in Body Composition and Cardiometabolic Risk in Overweight/Obese Adults

for
Dyslipidemia, Insulin Resistance Syndrome, Hypertension,
Location: Kennesaw GA
Sponsor: Kennesaw State University

Sex: All

Age: 20+

Code: NCT07221279

Recruiting

Human Observatory Study

for
Aging, Mortality, All-cause Mortality, Life Expectancy,
Location: Boulder CO
Sponsor: Longevity Metrics, Inc.

Sex: All

Age: 18+

Code: NCT07646782

Recruiting

100-Year Human Aging Study

for
Aging, Aging Well, All-Cause Mortality, Mortality,
Location: Boulder CO
Sponsor: Longevity Metrics, Inc.

Sex: All

Age: 18+

Code: NCT07563777

Recruiting

Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions

for
Hypertension, Type 2 Diabetes
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 18 - 60

Code: NCT05168605

Recruiting

An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)

for
Pulmonary Arterial Hypertension
Location: Boston MA, Valhalla NY, New York NY, Durham NC,
Sponsor: Inhibikase Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07365332

Phase 3, Recruiting

What is pulmonary hypertension?

Pulmonary hypertension is raised blood pressure in the arteries that carry blood from the heart to the lungs. Over time the right side of the heart has to pump harder against that pressure, and it can weaken and fail. Symptoms come on slowly: breathlessness with activity, tiredness, chest pressure, dizziness or fainting, and swelling in the ankles or belly. Because these signs look like asthma, heart disease, or simply being out of shape, the diagnosis is often delayed. It is suspected on an echocardiogram and confirmed by right heart catheterization, which measures the pressure directly.

Doctors sort pulmonary hypertension into five groups by cause, and the group decides the treatment. Group 1 is pulmonary arterial hypertension, or PAH, a rare disease of the small lung arteries themselves, which can be idiopathic, inherited, or linked to conditions such as scleroderma. Group 2, the most common, comes from left sided heart disease; group 3 from lung diseases such as COPD and pulmonary fibrosis; group 4 from old blood clots in the lungs, which surgery can sometimes cure; and group 5 from other or mixed causes. Most PAH medicines are approved only for group 1, which is why most drug trials enroll people with PAH.

Types of pulmonary hypertension clinical trials

Who can participate in pulmonary hypertension clinical trials?

Groups and functional class, and why they matter for trials

How to enroll in a pulmonary hypertension clinical trial